C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection

Hugo A Farne, Natasha K Martin, Janice Main, Timothy Orchard, Jonathan Tyrrell-Price

Research output: Contribution to journalArticle (Academic Journal)peer-review

4 Citations (Scopus)

Abstract

To assess the ability of C-reactive (CRP) protein, against the other commonly used metrics, to predict metronidazole treatment failure in Clostridium difficile infection.
Original languageEnglish
Pages (from-to)33-6
Number of pages4
JournalEuropean Journal of Gastroenterology and Hepatology
Volume25
Issue number1
DOIs
Publication statusPublished - Jan 2013

Keywords

  • Severity of Illness Index
  • Metronidazole
  • Anti-Infective Agents
  • Treatment Failure
  • Odds Ratio
  • Humans
  • Retrospective Studies
  • Aged
  • Predictive Value of Tests
  • Leukocyte Count
  • C-Reactive Protein
  • Drug Substitution
  • Creatinine
  • Aged, 80 and over
  • Logistic Models
  • Vancomycin
  • Middle Aged
  • Clostridium difficile
  • Clostridium Infections
  • Time Factors
  • Male
  • Biological Markers
  • Female

Fingerprint Dive into the research topics of 'C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection'. Together they form a unique fingerprint.

Cite this